4//SEC Filing
Lu Hongbo 4
Accession 0001562180-22-006567
CIK 0001831363other
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 8:00 PM ET
Size
5.3 KB
Accession
0001562180-22-006567
Insider Transaction Report
Form 4
Lu Hongbo
Director
Transactions
- Purchase
Common Stock
2022-09-07$3.60/sh+600,000$2,160,000→ 3,581,592 total(indirect: See Footnote)
Footnotes (1)
- [F1]The securities are held of record by Vivo Opportunity Fund Holdings, L.P. Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P. As a managing member of Vivo Opportunity, LLC, Hongbo Lu shares voting and dispositive power over the securities held by Vivo Opportunity Fund Holdings, L.P. with four other managing members but disclaims beneficial ownership over such securities except to the extent of her pecuniary interest therein.
Documents
Issuer
Terns Pharmaceuticals, Inc.
CIK 0001831363
Entity typeother
Related Parties
1- filerCIK 0001767584
Filing Metadata
- Form type
- 4
- Filed
- Sep 7, 8:00 PM ET
- Accepted
- Sep 8, 8:00 PM ET
- Size
- 5.3 KB